Hpb-092
Relapsed and Refractory Acute Myeloid Leukemia (RR-AML)
Hangzhou Polymed Biopharmaceuticals, Inc.Phase 1
—
Rating in progress
Hpb-092 in Relapsed and Refractory Acute Myeloid Leukemia (RR-AML) is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active